✦ LIBER ✦

Salvage treatment in male patients with germ cell tumours

✍ Scribed by Josefsen, D; Ous, S; Høie, J; Stenwig, AE; Fosså, SD

Book ID: 109836838
Publisher: Nature Publishing Group
Year: 1993
Tongue: English
Weight: 910 KB
Volume: 67
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1993.104

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum alpha1-foetoprotein levels in 153

Serum alpha1-foetoprotein levels in 153 male patients with germ cell tumours

✍ Grigor, K M; Detre, S I; Kohn, J; Neville, A M 📂 Article 📅 1977 🏛 Nature Publishing Group 🌐 English ⚖ 943 KB

Spontaneous acute tumour lysis syndrome

Spontaneous acute tumour lysis syndrome in patients with metastatic germ cell tumours

✍ G. Pentheroudakis; V. O'Neill; P. Vasey; S. Kaye 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 29 KB

Angiogenic factors in serum of patients

Angiogenic factors in serum of patients with testicular germ cell tumours

✍ Ferrero, Simone 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 110 KB

Young male patient with bilateral synchr

Young male patient with bilateral synchronous testicular germ cell tumour. Considerations for partial orchiectomy

✍ Joan Manel Gasent Blesa; Juan Laforga Canales; Pedro Romero Pérez; Manuel Amat C 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 241 KB

Long-term results of a combination of pa

Long-term results of a combination of paclitaxel, cisplatin and gemcitabine for salvage therapy in male germ-cell tumours

✍ Nicola Nicolai; Andrea Necchi; Luca Gianni; Luigi Piva; Davide Biasoni; Tullio T 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Salvage high-dose chemotherapy in patien

Salvage high-dose chemotherapy in patients with germ cell tumors : An Italian experience with 84 patients

✍ Giovanni Rosti; Ugo De Giorgi; Roberto Salvioni; Giorgio Papiani; Loretta Sebast 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract ## BACKGROUND High‐dose chemotherapy (HDCT) followed by hematopoietic stem cell support (HSCS) potentially may be curative in patients with germ cell tumor (GCT) who develop recurrent tumors or who have an inadequate response after receiving standard‐dose chemotherapy. The authors repo